SPSIPB for Breast Cancer Surgery
Launched by ZONGULDAK BULENT ECEVIT UNIVERSITY · Jan 17, 2024
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18-65 years old
- • ASA I-II-III risk group
- • Patients whose consent was obtained with an informed consent form
- • Breast Cancer Surgery operation patients who will undergo
- Exclusion Criteria:
- • Under 18 and over 65
- • ASA ≥ IV
- • History of allergy to local anesthetics
- • Known coagulation disorders
- • Infection near the entry site
- • Chronic use of analgesics
- • Diabetes Mellitus and patients receiving neoadjuvant chemotherapy
- • Body Mass index over 30
- • Dementia or confusion
- • Lack of cooperation
About Zonguldak Bulent Ecevit University
Zonguldak Bülent Ecevit University is a distinguished academic institution located in Turkey, dedicated to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university actively sponsors clinical trials that aim to enhance healthcare outcomes and contribute to scientific knowledge. Its multidisciplinary approach fosters a dynamic environment for researchers, clinicians, and students, promoting the development of novel therapeutic interventions and evidence-based practices. Through rigorous ethical standards and a commitment to excellence, Zonguldak Bülent Ecevit University plays a pivotal role in the advancement of medical science and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zonguldak, Kozlu, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported